Selected article for: "IFN pretreatment and STAT1 activation"
Author: Kumari G. Lokugamage; Adam Hage; Craig Schindewolf; Ricardo Rajsbaum; Vineet D. Menachery
Title: SARS-CoV-2 is sensitive to type I interferon pretreatment
  • Document date: 2020_3_9
    • ID: 2w0zr9c0_39
    Snippet: CoV-2 infection likely impacts its ability to inhibit the IFN-I response and eventual STAT1 231 activation. Similarly, while NSP3 deubiquitinating domain remains intact, SARS-CoV-2 has a 24 232 AA insertion upstream of this deubiquitinating domain that could potentially alter that function 233 (30). While other antagonists are maintained with high levels of conservation (>90%), single 234 point mutations in key locations could modify function and.....
    Document: CoV-2 infection likely impacts its ability to inhibit the IFN-I response and eventual STAT1 231 activation. Similarly, while NSP3 deubiquitinating domain remains intact, SARS-CoV-2 has a 24 232 AA insertion upstream of this deubiquitinating domain that could potentially alter that function 233 (30). While other antagonists are maintained with high levels of conservation (>90%), single 234 point mutations in key locations could modify function and contribute to increased IFN 235 sensitivity. Overall, the sequence analysis suggests that differences between SARS-CoV and 236 SARS-CoV-2 viral proteins may drive attenuation in the context of type I IFN pretreatment. 237

    Search related documents:
    Co phrase search for related documents
    • conservation high level and high level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • conservation high level and sequence analysis: 1
    • conservation high level and viral protein: 1, 2, 3
    • function modify and IFN response: 1, 2
    • function modify and viral protein: 1
    • high level and IFN pretreatment: 1
    • high level and IFN response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • high level and key location: 1, 2
    • high level and SARS viral protein: 1
    • high level and sequence analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • high level and viral protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • IFN pretreatment and SARS viral protein: 1
    • IFN pretreatment and viral protein: 1, 2, 3, 4, 5
    • IFN response and intact remain: 1
    • IFN response and SARS viral protein: 1
    • IFN response and sequence analysis: 1, 2, 3, 4, 5
    • IFN response and viral protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • intact remain and viral protein: 1, 2, 3
    • SARS viral protein and viral protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25